Shireen S Ganapathi

6PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursMolecular targetsPaediatrics not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 27, 2025
Determining Preclinical Safety of Aclarubicin in Pediatric Malignancies.

Darleen S Tu, Aaron K Olson, Kimberly S Waggie

|Sep 26, 2025
Advancing Preclinical Biology for Ewing Sarcoma: An International Effort.

Filemon S Dela Cruz, Elizabeth A Stewart, Didier Surdez

|Sep 15, 2025
Transcriptional Rewiring of BET Inhibitor Treated Ewing Sarcoma Cells Augments their Dependency on Focal Adhesion Kinase.

Shireen S Ganapathi, Emma D Wrenn, Nicolas M Garcia

|Sep 05, 2025
Advancing Preclinical Biology for Ewing Sarcoma: An International Effort.

Filemon S Dela Cruz, Elizabeth A Stewart, Didier Surdez

|Jun 06, 2025
Determining preclinical safety of Aclarubicin in pediatric malignancies.

Darleen S Tu, Aaron K Olson, Kimberly S Waggie

|Mar 30, 2021
Mixed phenotype acute leukemia in a child associated with a NUP98-NSD1 fusion and NRAS p.Gly61Arg mutation.

Shireen S Ganapathi, Sunil S Raikar, Svetlana A Yatsenko

Pageof 1